Eeva™ System Clinical Study

To validate the Eeva technology, Auxogyn just completed enrollment in a multicenter clinical study which evaluated embryos from the following five IVF clinics in California:

The goal of this study is to demonstrate that Eeva may be used to identify embryos at cleavage stage (Day 3) that are most likely to form blastocysts (Day 5). These predictions will be compared to the actual blastocyst outcome as observed at the clinical sites. Further information on the criteria for patient eligibility and study methods is available at www.ClinicalTrials.gov.